Amphastar Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Amphastar Pharmaceuticals,

09/08/2023 09:23

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 65 cents​​ per share for the quarter ended
in June. The mean expectation of four analysts for the quarter
was for earnings of 56 cents per share.
    * Revenue rose 18% to $145.71 million from a year ago;
analysts
expected $137.37 million. 
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Amphastar Pharmaceuticals Inc shares had risen by 13.1%
this
quarter and gained 132.0% so far this year.
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $66.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 08:23 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.56           0.65           Beat
 Mar. 31 2023      0.48           0.62           Beat
 Dec. 31 2022      0.41           0.73           Beat
 Sep. 30 2022      0.39           0.38           Missed